255 related articles for article (PubMed ID: 9606287)
21. Postural variation of exophthalmometry in Graves' ophthalmopathy.
Asad R; Tewari HK; Ahuja MM; Mithal A
Indian J Ophthalmol; 1990; 38(4):166-8. PubMed ID: 2086467
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of Graves' disease: historical context and single institution experience.
Russell MJ; Young S; Martin R; Harman R
N Z Med J; 2022 Feb; 135(1549):43-49. PubMed ID: 35728139
[TBL] [Abstract][Full Text] [Related]
23. Surgery still has a role in Graves' hyperthyroidism.
Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
[TBL] [Abstract][Full Text] [Related]
24. Thyroid surgery for treatment of Graves' disease complicated by ophthalmopathy: a comprehensive review.
Wong J; Wiseman SM
Expert Rev Endocrinol Metab; 2015 May; 10(3):327-336. PubMed ID: 30298775
[TBL] [Abstract][Full Text] [Related]
25. Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule.
Boostrom S; Richards ML
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):278-81. PubMed ID: 17275554
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
[TBL] [Abstract][Full Text] [Related]
27. Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection.
Järhult J; Rudberg C; Larsson E; Selvander H; Sjövall K; Winsa B; Rastad J; Karlsson FA;
Thyroid; 2005 Oct; 15(10):1157-64. PubMed ID: 16279849
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
[TBL] [Abstract][Full Text] [Related]
29. Regression of ophthalmopathy in Graves' disease following thyroidectomy. A systematic study of changes of ocular signs.
Marushak D; Faurschou S; Blichert-Toft M
Acta Ophthalmol (Copenh); 1984 Oct; 62(5):767-79. PubMed ID: 6548857
[TBL] [Abstract][Full Text] [Related]
30. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
[TBL] [Abstract][Full Text] [Related]
31. Proptosis is associated with thiol-disulfide in patients with Graves' ophthalmopathy.
Acibucu F; Öztürk DD; Kizildag C; Aslan MZ; Gulumsek E; Sumbul MS; Neselioglu S; Erel O; Sen S; Bankir M; Sumbul HE
Arch Endocrinol Metab; 2022 Apr; 66(2):191-197. PubMed ID: 35315985
[TBL] [Abstract][Full Text] [Related]
32. Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
Ma EZ; Kuo JH; Malek R; Turner DJ; Olson JA; Slejko JF; Mullins CD; Hu Y
Surgery; 2023 Jan; 173(1):193-200. PubMed ID: 36208983
[TBL] [Abstract][Full Text] [Related]
33. Graves' disease associated with histologic Hashimoto's thyroiditis.
Falk SA; Birken EA; Ronquillo AH
Otolaryngol Head Neck Surg; 1985 Feb; 93(1):86-91. PubMed ID: 3920630
[TBL] [Abstract][Full Text] [Related]
34. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC
Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197
[TBL] [Abstract][Full Text] [Related]
35. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
[TBL] [Abstract][Full Text] [Related]
36. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine.
Teng CS; Yeung RT; Khoo RK; Alagaratnam TT
J Clin Endocrinol Metab; 1980 Jun; 50(6):1005-10. PubMed ID: 6103007
[TBL] [Abstract][Full Text] [Related]
38. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience.
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Y Hames K; Akaishi J; Masaki C; Ogimi Y; Yabuta T; Ito K
Endocr J; 2019 Feb; 66(2):181-186. PubMed ID: 30568070
[TBL] [Abstract][Full Text] [Related]
39. Graves' ophthalmopathy: natural history and treatment outcomes.
Noth D; Gebauer M; Müller B; Bürgi U; Diem P
Swiss Med Wkly; 2001 Oct; 131(41-42):603-9. PubMed ID: 11820071
[TBL] [Abstract][Full Text] [Related]
40. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy.
Kurihara H
Thyroid; 2002 Mar; 12(3):265-7. PubMed ID: 11952051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
